Clinical Trials Logo
  1. Home
  2. Cancers
  3. NCT01295658
  4. Details
NCT01295658 Clinical Trial

Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project

Cancers Clinical Trial

Official title:
Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01295658
Other study ID # CSC-MAP-0102
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2010
Est. completion date March 2013

Study information
Verified date July 2020
Source Cancer Support Community, Research and Training Institute, Philadelphia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.

Description:

The Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project was the first registry of its kind to look at the emotional and social needs of individuals diagnosed with breast cancer and track how their needs changed throughout their cancer journey. Data will raise awareness and help develop programs to address the needs of breast cancer survivors. Findings from the Registry are disseminated online at www.CancerSupportCommunity.org/RegistryIndexReport2017

Recruitment information / eligibility
Status Completed
Enrollment 3729
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Having received a cancer diagnosis

Exclusion Criteria:

- None

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Cancer Support Community Research & Training Institute Philadelphia Pennsylvania

Sponsors (1)
Lead Sponsor Collaborator
Cancer Support Community, Research and Training Institute, Philadelphia

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Self-reported quality of life measures 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT01127711 - Cohort of Swedish Men N/A
Recruiting NCT05299710 - Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Completed NCT01127698 - Swedish Mammography Cohort N/A
Completed NCT02734303 - Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test
Completed NCT01646437 - The International Polycap Study 3 (TIPS-3) Phase 3
Completed NCT01441674 - Animal Assisted Therapy in a Pediatric Setting Phase 1/Phase 2
Completed NCT04198896 - The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Completed NCT01185470 - The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain Phase 2/Phase 3
Completed NCT00484016 - Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC N/A
Completed NCT03378895 - CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne N/A
Recruiting NCT06046066 - A Phase 1 Study of NM6603 in Advanced Solid Tumors Phase 1
Not yet recruiting NCT06416267 - Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

External Links